CardioComm Solutions, Inc.
EKGGF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -38.8% | -28% | -41.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -174.6% | 76.6% | 93.6% | 91.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -393.1% | -175.8% | -85.7% | -10.7% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -276.6% | -172.5% | -18.1% | -54.4% |
| EPS | -0.001 | -0.001 | -0 | -0.001 |
| % Growth | -66.7% | -500% | 80% | – |
| EPS Diluted | -0.001 | -0.001 | -0 | -0.001 |
| Weighted Avg Shares Out | 196 | 193 | 193 | 180 |
| Weighted Avg Shares Out Dil | 196 | 193 | 193 | 180 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -338.9% | -184.7% | -5.1% | 55.2% |